Amarin Corp Plc (AMRN)

[sblfe]

JL, HD, AVI, or anyone of the heavyweights here- Can you give your thoughts on the wide disparity between the results in the US vs non-US for both CV death (-34% vs -5%) and Total Mortality (-30% vs +4%)? What could be accounting for such a large difference? Does the wide disparity create a statistical anomaly in the results? I could see the healthcare system in emerging markets as a contributor but Europe is a large portion of the non-US cohort. I'd appreciate your thoughts when you get a chance. Thanks!